Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Airway Management | 5 | 2020 | 55 | 2.750 |
Why?
|
| Prostatic Neoplasms | 11 | 2023 | 339 | 1.950 |
Why?
|
| Critical Illness | 5 | 2020 | 325 | 1.800 |
Why?
|
| Intensive Care Units | 9 | 2022 | 423 | 1.220 |
Why?
|
| Catheterization, Central Venous | 4 | 2015 | 84 | 1.180 |
Why?
|
| Critical Care | 7 | 2016 | 397 | 1.170 |
Why?
|
| Catheter-Related Infections | 3 | 2015 | 41 | 1.140 |
Why?
|
| Bacteremia | 4 | 2019 | 91 | 1.030 |
Why?
|
| Specialization | 2 | 2012 | 78 | 0.790 |
Why?
|
| Anesthesiology | 2 | 2012 | 40 | 0.790 |
Why?
|
| Communication Aids for Disabled | 1 | 2022 | 5 | 0.780 |
Why?
|
| Communication Disorders | 1 | 2022 | 16 | 0.760 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2022 | 31 | 0.760 |
Why?
|
| Intubation, Intratracheal | 4 | 2019 | 194 | 0.720 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2021 | 71 | 0.680 |
Why?
|
| Conscious Sedation | 1 | 2019 | 38 | 0.640 |
Why?
|
| Radiology, Interventional | 1 | 2019 | 28 | 0.630 |
Why?
|
| Cystectomy | 3 | 2021 | 24 | 0.530 |
Why?
|
| Prostate-Specific Antigen | 6 | 2023 | 66 | 0.520 |
Why?
|
| Prostatectomy | 3 | 2014 | 64 | 0.520 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 255 | 0.510 |
Why?
|
| Central Venous Catheters | 1 | 2015 | 15 | 0.480 |
Why?
|
| Chlorhexidine | 2 | 2015 | 17 | 0.470 |
Why?
|
| Catheters, Indwelling | 3 | 2010 | 67 | 0.460 |
Why?
|
| Humans | 45 | 2023 | 59389 | 0.460 |
Why?
|
| Cross Infection | 2 | 2019 | 149 | 0.440 |
Why?
|
| Postoperative Complications | 4 | 2021 | 1204 | 0.420 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2010 | 49 | 0.410 |
Why?
|
| Patient Care Team | 1 | 2015 | 327 | 0.390 |
Why?
|
| Mass Screening | 2 | 2008 | 648 | 0.390 |
Why?
|
| Lumbar Vertebrae | 1 | 2013 | 137 | 0.380 |
Why?
|
| Spinal Fusion | 1 | 2013 | 124 | 0.380 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 402 | 0.360 |
Why?
|
| Silver Sulfadiazine | 1 | 2010 | 3 | 0.360 |
Why?
|
| Antimetabolites | 1 | 2010 | 17 | 0.360 |
Why?
|
| Fluorouracil | 1 | 2010 | 55 | 0.350 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 27 | 0.350 |
Why?
|
| Oxygen | 3 | 2007 | 313 | 0.340 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2010 | 62 | 0.340 |
Why?
|
| Regression Analysis | 5 | 2015 | 486 | 0.340 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2020 | 83 | 0.340 |
Why?
|
| Kidney Neoplasms | 3 | 2020 | 125 | 0.330 |
Why?
|
| Hypoxia | 2 | 2012 | 112 | 0.330 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2010 | 119 | 0.310 |
Why?
|
| Male | 27 | 2023 | 27747 | 0.310 |
Why?
|
| Middle Aged | 22 | 2023 | 16314 | 0.300 |
Why?
|
| Equipment Contamination | 1 | 2008 | 31 | 0.300 |
Why?
|
| Aged, 80 and over | 15 | 2021 | 5119 | 0.300 |
Why?
|
| Urethral Obstruction | 1 | 2008 | 6 | 0.300 |
Why?
|
| Ejaculation | 1 | 2007 | 8 | 0.280 |
Why?
|
| Genital Diseases, Male | 1 | 2007 | 7 | 0.280 |
Why?
|
| Embolism, Fat | 1 | 2007 | 2 | 0.280 |
Why?
|
| Surgical Wound Infection | 2 | 2017 | 110 | 0.280 |
Why?
|
| Urology | 2 | 2020 | 36 | 0.280 |
Why?
|
| Polymethyl Methacrylate | 1 | 2007 | 14 | 0.280 |
Why?
|
| Bone Cements | 1 | 2007 | 16 | 0.280 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 300 | 0.270 |
Why?
|
| Aged | 20 | 2023 | 13406 | 0.260 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2006 | 88 | 0.250 |
Why?
|
| Lung Diseases | 1 | 2007 | 170 | 0.240 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2020 | 75 | 0.240 |
Why?
|
| Adult | 20 | 2023 | 15683 | 0.240 |
Why?
|
| Risk Factors | 10 | 2023 | 4986 | 0.240 |
Why?
|
| Staphylococcal Infections | 2 | 2017 | 122 | 0.230 |
Why?
|
| Retrospective Studies | 13 | 2021 | 6071 | 0.230 |
Why?
|
| Lymph Node Excision | 2 | 2014 | 38 | 0.220 |
Why?
|
| Treatment Outcome | 11 | 2020 | 5281 | 0.210 |
Why?
|
| Neoplasm Staging | 5 | 2014 | 448 | 0.200 |
Why?
|
| Radiotherapy Dosage | 1 | 2022 | 81 | 0.190 |
Why?
|
| Comorbidity | 3 | 2013 | 1078 | 0.190 |
Why?
|
| Logistic Models | 8 | 2017 | 1234 | 0.180 |
Why?
|
| Spinal Cord Ischemia | 1 | 2020 | 16 | 0.170 |
Why?
|
| Sarcopenia | 1 | 2020 | 18 | 0.170 |
Why?
|
| Fungemia | 1 | 2019 | 6 | 0.160 |
Why?
|
| Renal Insufficiency | 1 | 2020 | 65 | 0.160 |
Why?
|
| Neoadjuvant Therapy | 1 | 2020 | 71 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 789 | 0.160 |
Why?
|
| Drainage | 1 | 2020 | 150 | 0.160 |
Why?
|
| Aortic Aneurysm | 1 | 2020 | 81 | 0.160 |
Why?
|
| Female | 17 | 2021 | 30724 | 0.160 |
Why?
|
| Laryngoscopy | 1 | 2019 | 61 | 0.160 |
Why?
|
| Risk Assessment | 5 | 2023 | 1925 | 0.150 |
Why?
|
| Incidence | 3 | 2023 | 1238 | 0.150 |
Why?
|
| Perioperative Care | 2 | 2010 | 76 | 0.150 |
Why?
|
| United States | 5 | 2019 | 7426 | 0.140 |
Why?
|
| Follow-Up Studies | 5 | 2014 | 2338 | 0.140 |
Why?
|
| Anesthesia, Conduction | 1 | 2017 | 10 | 0.140 |
Why?
|
| Subclavian Artery | 1 | 2017 | 24 | 0.140 |
Why?
|
| Surgical Procedures, Operative | 2 | 2016 | 137 | 0.140 |
Why?
|
| Communication | 1 | 2022 | 546 | 0.140 |
Why?
|
| Candidemia | 1 | 2017 | 10 | 0.140 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2017 | 24 | 0.140 |
Why?
|
| Early Ambulation | 1 | 2016 | 6 | 0.140 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2007 | 9 | 0.130 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2017 | 29 | 0.130 |
Why?
|
| Pseudomonas Infections | 1 | 2017 | 51 | 0.130 |
Why?
|
| Spinal Cord Compression | 2 | 2007 | 28 | 0.130 |
Why?
|
| Inpatients | 1 | 2019 | 292 | 0.130 |
Why?
|
| Physical Therapy Modalities | 1 | 2016 | 45 | 0.130 |
Why?
|
| Patient Care Planning | 1 | 2016 | 84 | 0.130 |
Why?
|
| Lymph Nodes | 2 | 2014 | 215 | 0.130 |
Why?
|
| Germany | 3 | 2016 | 52 | 0.130 |
Why?
|
| Radiology | 1 | 2020 | 236 | 0.130 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 96 | 0.120 |
Why?
|
| Disease Management | 1 | 2017 | 220 | 0.120 |
Why?
|
| Hand Hygiene | 1 | 2015 | 7 | 0.120 |
Why?
|
| Staphylococcus | 1 | 2015 | 16 | 0.120 |
Why?
|
| Single-Blind Method | 2 | 2016 | 136 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 76 | 0.120 |
Why?
|
| Aortic Valve Stenosis | 1 | 2017 | 170 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 103 | 0.110 |
Why?
|
| Blood Component Transfusion | 1 | 2013 | 8 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2014 | 133 | 0.110 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 609 | 0.110 |
Why?
|
| Hospital Charges | 1 | 2013 | 23 | 0.110 |
Why?
|
| Intubation | 1 | 2012 | 11 | 0.100 |
Why?
|
| Demography | 1 | 2013 | 169 | 0.100 |
Why?
|
| Laryngoscopes | 1 | 2012 | 22 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2007 | 674 | 0.100 |
Why?
|
| Hypotension | 1 | 2012 | 48 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 180 | 0.100 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 243 | 0.090 |
Why?
|
| Prevalence | 2 | 2013 | 1253 | 0.090 |
Why?
|
| Robotic Surgical Procedures | 1 | 2014 | 115 | 0.090 |
Why?
|
| Colony Count, Microbial | 1 | 2010 | 57 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2013 | 292 | 0.090 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 26 | 0.090 |
Why?
|
| Antisepsis | 1 | 2010 | 7 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 85 | 0.080 |
Why?
|
| Gram-Positive Bacteria | 1 | 2010 | 36 | 0.080 |
Why?
|
| Length of Stay | 1 | 2013 | 776 | 0.080 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 92 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2013 | 492 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2023 | 1027 | 0.080 |
Why?
|
| Ohio | 1 | 2008 | 24 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2010 | 1051 | 0.080 |
Why?
|
| Catheterization, Peripheral | 1 | 2008 | 46 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2008 | 461 | 0.070 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2007 | 26 | 0.070 |
Why?
|
| Hypovolemia | 1 | 2007 | 16 | 0.070 |
Why?
|
| Age Distribution | 1 | 2008 | 249 | 0.070 |
Why?
|
| Equipment Design | 1 | 2008 | 329 | 0.070 |
Why?
|
| Hand Strength | 1 | 2007 | 28 | 0.070 |
Why?
|
| Erectile Dysfunction | 1 | 2007 | 23 | 0.070 |
Why?
|
| Immobilization | 1 | 2007 | 12 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2014 | 2375 | 0.070 |
Why?
|
| Neuromuscular Agents | 1 | 2007 | 16 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 674 | 0.070 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 81 | 0.070 |
Why?
|
| Veins | 1 | 2007 | 61 | 0.070 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2006 | 2 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 206 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 62 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2008 | 554 | 0.070 |
Why?
|
| Hypothermia | 1 | 2006 | 19 | 0.070 |
Why?
|
| Nomograms | 1 | 2006 | 12 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2007 | 115 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2007 | 230 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 2 | 2020 | 248 | 0.070 |
Why?
|
| Transfusion Reaction | 1 | 2006 | 44 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 132 | 0.060 |
Why?
|
| Cervical Vertebrae | 1 | 2007 | 101 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 92 | 0.060 |
Why?
|
| Time Factors | 4 | 2021 | 3615 | 0.060 |
Why?
|
| Emergencies | 1 | 2005 | 110 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 902 | 0.060 |
Why?
|
| Adolescent | 3 | 2015 | 5838 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 1559 | 0.060 |
Why?
|
| Pain | 1 | 2007 | 396 | 0.060 |
Why?
|
| Biopsy | 3 | 2014 | 410 | 0.060 |
Why?
|
| Disease Progression | 1 | 2008 | 1119 | 0.050 |
Why?
|
| Europe | 2 | 2014 | 182 | 0.050 |
Why?
|
| Obesity | 1 | 2011 | 1166 | 0.050 |
Why?
|
| Norway | 1 | 2023 | 18 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2010 | 3067 | 0.050 |
Why?
|
| Age Factors | 1 | 2007 | 1504 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1479 | 0.050 |
Why?
|
| Survival Rate | 2 | 2015 | 801 | 0.050 |
Why?
|
| Post-Dural Puncture Headache | 1 | 2020 | 5 | 0.040 |
Why?
|
| Cerebral Intraventricular Hemorrhage | 1 | 2020 | 9 | 0.040 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2020 | 15 | 0.040 |
Why?
|
| Image-Guided Biopsy | 1 | 2020 | 36 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2020 | 37 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2008 | 2516 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2020 | 77 | 0.040 |
Why?
|
| Exercise | 1 | 2007 | 883 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2020 | 66 | 0.040 |
Why?
|
| Cisplatin | 1 | 2020 | 119 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 2020 | 95 | 0.040 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 93 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2020 | 228 | 0.040 |
Why?
|
| Blood Culture | 1 | 2017 | 11 | 0.030 |
Why?
|
| APACHE | 1 | 2017 | 46 | 0.030 |
Why?
|
| Posture | 1 | 2017 | 127 | 0.030 |
Why?
|
| Area Under Curve | 2 | 2007 | 141 | 0.030 |
Why?
|
| Austria | 1 | 2016 | 7 | 0.030 |
Why?
|
| Soft Tissue Infections | 1 | 2017 | 45 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 69 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 651 | 0.030 |
Why?
|
| Hospital Mortality | 2 | 2011 | 842 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 84 | 0.030 |
Why?
|
| Stents | 1 | 2020 | 461 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2017 | 80 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 914 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 403 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 450 | 0.030 |
Why?
|
| Mortality | 1 | 2017 | 155 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 186 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 308 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 628 | 0.030 |
Why?
|
| Kallikreins | 1 | 2014 | 8 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 79 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 74 | 0.030 |
Why?
|
| Pelvis | 1 | 2014 | 57 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 4272 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 555 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 589 | 0.030 |
Why?
|
| Patient Selection | 1 | 2014 | 465 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 974 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2010 | 52 | 0.020 |
Why?
|
| Rifampin | 1 | 2010 | 23 | 0.020 |
Why?
|
| Minocycline | 1 | 2010 | 24 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 2010 | 58 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2011 | 148 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 746 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 143 | 0.020 |
Why?
|
| Lower Body Negative Pressure | 1 | 2007 | 8 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2007 | 48 | 0.020 |
Why?
|
| Blood Volume | 1 | 2007 | 42 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2007 | 9 | 0.020 |
Why?
|
| Physical Examination | 1 | 2007 | 104 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2007 | 76 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2007 | 71 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 92 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 409 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 1284 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2007 | 126 | 0.020 |
Why?
|
| Heart Rate | 1 | 2007 | 307 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1492 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 52 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2007 | 314 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 295 | 0.020 |
Why?
|
| ROC Curve | 1 | 2006 | 267 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2010 | 1793 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2007 | 496 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2007 | 283 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2007 | 521 | 0.010 |
Why?
|
| Skin | 1 | 2007 | 357 | 0.010 |
Why?
|
| Massachusetts | 1 | 2010 | 2019 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 1597 | 0.010 |
Why?
|
| Child | 1 | 2010 | 4189 | 0.010 |
Why?
|